Open AccessShort-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients
Author(s) -
Dominic Chow,
Huichao Chen,
Marshall J. Glesby,
Anthony J. Busti,
Scott Souza,
Janet Andersen,
Sharon Kohrs,
Julia Wu,
Susan L. Koletar
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32833068e3
Subject(s) - ezetimibe , medicine , placebo , interquartile range , gastroenterology , tolerability , cholesterol , statin , triglyceride , endocrinology , adverse effect , alternative medicine , pathology
Ezetimibe inhibits intestinal absorption of cholesterol.